US 11,753,398 B2
Therapeutic compounds
Barrie P. Martin, Manchester (GB)
Assigned to C4X Discovery Limited, Manchester (GB)
Filed by C4X Discovery Limited, Manchester (GB)
Filed on Aug. 27, 2021, as Appl. No. 17/459,598.
Application 17/459,598 is a division of application No. 16/860,572, filed on Apr. 28, 2020, granted, now 11,130,746.
Application 16/860,572 is a continuation of application No. 16/073,429, granted, now 10,696,654, previously published as PCT/EP2017/051960, filed on Jan. 30, 2017.
Claims priority of application No. 1601703 (GB), filed on Jan. 29, 2016.
Prior Publication US 2021/0395227 A1, Dec. 23, 2021
Int. Cl. C07D 401/14 (2006.01)
CPC C07D 401/14 (2013.01) 3 Claims
 
1. (2S)-N2-methyl-N1-(5-(trifluoromethyl)pyrazin-2-yl)propane-1,2-diamine:

OG Complex Work Unit Chemistry
or a salt thereof.